InsidersTradesSigma
Track the Nephro Care India Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €67.7bn. The latest transaction was filed on 28 March 2026 (Purchase). Among the most active insiders: Ranita Bose. Every trade is openly available.
Analysts rate Nephro Care India Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹771.25.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Nephro Care India Limited 是一家专注于印度肾脏护理的公司。它提供透析服务和肾脏疾病治疗。